SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-038851
Filing Date
2022-03-28
Accepted
2022-03-28 17:08:39
Documents
14
Period of Report
2022-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2210607d1_8k.htm   iXBRL 8-K 30668
2 EXHIBIT 10.1 tm2210607d1_ex10-1.htm EX-10.1 17089
3 EXHIBIT 10.2 tm2210607d1_ex10-2.htm EX-10.2 30954
  Complete submission text file 0001104659-22-038851.txt   267854

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA armp-20220325.xsd EX-101.SCH 3045
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20220325_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20220325_pre.xml EX-101.PRE 22603
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2210607d1_8k_htm.xml XML 3491
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 22776280
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences